Extrinsic Amyloid-Binding Dyes for the Detection of Individual Protein Aggregates in Solution
Authors
Klenerman, D
Publication Date
2018-09-04Journal Title
Analytical Chemistry
ISSN
1520-6882
Publisher
American Chemical Society (ACS)
Volume
90
Issue
17
Pages
10385-10393
Type
Article
Metadata
Show full item recordCitation
Klenerman, D. (2018). Extrinsic Amyloid-Binding Dyes for the Detection of Individual Protein Aggregates in Solution. Analytical Chemistry, 90 (17), 10385-10393. https://doi.org/10.1021/acs.analchem.8b02226
Abstract
Protein aggregation is a key molecular feature underlying a wide array of neurodegenerative disorders, including Alzheimer's and Parkinson's diseases. To understand protein aggregation in molecular detail it is crucial to be able to characterise the array of heterogeneous aggregates that are formed during the aggregation process. We present here a high-throughput method to detect single protein aggregates, in solution, from a label-free aggregation reaction and demonstrate the approach with the protein associated with Parkinson's disease, alpha synuclein. The method combines single-molecule confocal microscopy with a range of amyloid-binding extrinsic dyes, including thioflavin T and pentameric formyl thiophene acetic acid, and we show that we can observe aggregates at low picomolar concentrations. The detection of individual aggregates allows us to quantify their numbers. Furthermore, we show that this approach also allows us to gain structural insights from the emission intensity of the extrinsic dyes that are bound to aggregates. By analysing the time evolution of the aggregate populations on a single-molecule level, we then estimate the fragmentation rate of aggregates, a key process which underlies the multiplication of pathological aggregates. We additionally demonstrate that the method permits the detection of these aggregates in biological samples. The capability to detect individual protein aggregates in solution opens up a range of new applications, including exploiting the potential of this method for high-throughput screening of human biofluids for disease diagnosis and early detection.
Keywords
0601 Biochemistry and Cell Biology, Biomedical, Basic Science, Prevention, Dementia, Neurosciences, Acquired Cognitive Impairment, Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD), Aging, Brain Disorders, Neurodegenerative, Alzheimer's Disease, Neurological, Generic Health Relevance, 1.1 Normal biological development and functioning, 2.1 Biological and endogenous factors, 4.1 Discovery and preclinical testing of markers and technologies
Sponsorship
ERC and Royal society
Funder references
European Research Council (669237)
Royal Society (RP/EA/180002)
Royal Society (RP150066)
Medical Research Council (MC_G1000734)
Engineering and Physical Sciences Research Council (EP/P008224/1)
European Research Council (337969)
Embargo Lift Date
2100-01-01
Identifiers
External DOI: https://doi.org/10.1021/acs.analchem.8b02226
This record's URL: https://www.repository.cam.ac.uk/handle/1810/284641
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk